Company Filing History:
Years Active: 1986
Title: Motoyoshi Miyake: Innovator in Corticoid Derivatives
Introduction
Motoyoshi Miyake is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of corticoid derivatives. With a total of 2 patents, his work has had a substantial impact on the treatment of various skin conditions and asthma.
Latest Patents
Miyake's latest patents include innovative compounds that exhibit strong topical anti-inflammatory activity. The first patent focuses on novel corticoid 17.alpha.-alkoxycarbonyl carboxylate derivatives. These derivatives are noted for their effectiveness in treating acute and chronic eczema, eczema seborrhoicorum, contact dermatitis, atopic dermatitis, and asthma, while also demonstrating extremely weak systemic adverse reactions. The second patent involves 6-oxygenated corticoid 17.alpha.-carbonates, which similarly provide strong topical anti-inflammatory effects with minimal systemic side effects. These compounds are also useful in treating the same conditions as the first patent.
Career Highlights
Miyake is associated with Mitsubishi Chemical Industries Limited, where he has been able to apply his expertise in pharmaceutical innovation. His work has contributed to the advancement of treatments that improve the quality of life for patients suffering from various dermatological and respiratory conditions.
Collaborations
Miyake has collaborated with notable colleagues, including Issei Nitta and Akira Maruyama. Their combined efforts have furthered research and development in the field of corticoid derivatives.
Conclusion
Motoyoshi Miyake's contributions to the field of pharmaceuticals through his innovative patents have made a significant impact on the treatment of skin and respiratory conditions. His work continues to influence the development of effective therapies that benefit patients worldwide.